Show simple item record

dc.contributor.authorRodríguez Mañero, Moises 
dc.contributor.authorKreidieh, B.
dc.contributor.authorValderrabano, M.
dc.contributor.authorBaluja González, María Aurora 
dc.contributor.authorMartínez Sande, Jose Luis 
dc.contributor.authorGarcía Seara, Javier 
dc.contributor.authorDíaz Fernández, Brais 
dc.contributor.authorPereira Vázquez, María 
dc.contributor.authorLage Fernández, Ricardo
dc.contributor.authorGonzález Melchor, Laila
dc.contributor.authorFernández López, Jesus Alberto 
dc.contributor.authorGonzález Juanatey, José Ramón 
dc.date.accessioned2021-11-23T09:13:41Z
dc.date.available2021-11-23T09:13:41Z
dc.date.issued2019
dc.identifier.issn1880-4276
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/30805040es]bi
dc.identifier.urihttp://hdl.handle.net/20.500.11940/15721
dc.description.abstractSupraventricular arrhythmias are common in Brugada syndrome (BS), and notoriously difficult to manage with medical therapy secondary to associated risks. Pulmonary vein isolation (PVI) is often utilized instead, but its outcomes in this population are not well-known. We aim to provide a holistic evaluation of interventional treatment for Atrial fibrillation (AF) in the BS population. Electronic databases Medline, Embase, Cinahl, Cochrane, and Scopus were systematically searched for publications between 01/01/1995 and 12/31/2017. Studies were screened based on predefined inclusion and exclusion criteria. A total of 49 patients with BS and AF were included. Age range from 28.8 to 64 years, and 77.5% were male. 38 patients were implanted with implantable cardioverter-defibrillators (ICD) at baseline, and of them, 39% suffered inappropriate shocks for rapid AF. 34/49 (69%) of patients achieved remission following a single PVI procedure. Of the remaining, 13 patients underwent one or more repeat ablation procedures. Overall, 45/49 (91.8%) of patients remained in remission during long-term follow-up after one or more PVI procedures in the absence of antiarrhythmic drug (AAD) therapy. Postablation, no patients suffered inappropriate ICD shock. Furthermore, no major complications secondary to PVI occurred in any patient. AF ablation achieves acute and long-term success in the vast majority of patients. It is effective in preventing inappropriate ICD therapy secondary to rapid AF. Complication rates of PVI in BS are low. Thus, in light of the risks of AADs and risk of inappropriate ICD shocks in the BS population, catheter ablation could represent an appropriate first-line therapy for paroxysmal atrial fibrillation in BS patients.es
dc.language.isoenges
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshBrugada Syndrome*
dc.titleAblation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literaturees
dc.typeArtigoes
dc.authorsophosRodriguez-Manero, M.
dc.authorsophosKreidieh, B.
dc.authorsophosValderrabano, M.
dc.authorsophosBaluja, A.
dc.authorsophosMartinez-Sande, J. L.
dc.authorsophosGarcia-Seara, J.
dc.authorsophosDiaz-Fernandez, B.
dc.authorsophosPereira-Vazquez, M.
dc.authorsophosLage, R.
dc.authorsophosGonzalez-Melchor, L.
dc.authorsophosFernandez-Lopez, X. A.
dc.authorsophosGonzalez-Juanatey, J. R.
dc.identifier.doi10.1002/joa3.12113
dc.identifier.pmid30805040
dc.identifier.sophos31462
dc.issue.number1es
dc.journal.titleJOURNAL OF ARRHYTHMIAes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Cardioloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.page.initial18es
dc.page.final24es
dc.rights.accessRightsopenAccesses
dc.subject.decssíndrome de brugada*
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo de Revisiónes
dc.typesophosArtículo de Revisiónes
dc.volume.number35es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International